Unkart Edward W 4
4 · KalVista Pharmaceuticals, Inc. · Filed Sep 29, 2017
Insider Transaction Report
Form 4
Unkart Edward W
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2017-09-27+6,000→ 6,000 totalExercise: $6.71Exp: 2027-09-26→ Common Stock (6,000 underlying)
Footnotes (1)
- [F1]The option vests over a 12 month period: 1/12th on October 27, 2017, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date.